Is there a detrimental effect of higher gonadotrophin dose on clinical pregnancy rate in normo-responders undergoing ART with long protocol?

Archives of Gynecology and Obstetrics

Volumn 287, Issue 5, 2013, Pages 1039-1044

  Yilmaz, Nafiye ^a,b   Yilmaz, Saynur ^a   Inal, Hasan ^a   Gorkem, Umit ^a   Seckin, Berna ^a   Turkkani, Ayten ^a   Gulerman, Cavidan ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

ART; Clinical pregnancy rate; Gonadotrophin dose

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LEUPRORELIN; RECOMBINANT FOLLITROPIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CELL COUNT; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG DOSE COMPARISON; DRUG MEGADOSE; EMBRYO TRANSFER; ENDOMETRIAL THICKNESS; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN CELL; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LOW DRUG DOSE; OOCYTE; OPTIMAL DRUG DOSE; OVARY FOLLICLE; OVULATION INDUCTION; PREDICTION; PREGNANCY RATE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY;

BODY MASS INDEX; CHORIONIC GONADOTROPIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; LEUPROLIDE; OOCYTES; OVULATION INDUCTION; PREGNANCY; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TISSUE AND ORGAN HARVESTING; TREATMENT OUTCOME; TURKEY;

EID: 84876669370     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2673-z     Document Type: Article

References (34)

1. Steptoe PC, Edwards RG (1978) Birth after the reimplantation of a human embryo. Lancet 2(8085):366 (Pubitemid 9007386)
2. Macklon NS, Stouffer RL, Giudice LC, Fauser BC (2006) The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev 27(2):170-207 (Epub 2006 Jan 24)
3. Kovacs P, Sajgo A, Kaali SG, Pal L (2012) Detrimental effects of high dose gonadotrophin on outcome of IVF: making a case for gentle ovarian stimulation strategies. Reprod Sci 19(7):718-724
4. Pal L, Jindal S, Witt BR, Santoro N (2008) Less is more: increased gonadotrophin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril 89(6):1694-1701 (Epub 2008 Apr 28)
5. FIVNAT 1996 report (1997) French National Register on In Vitro Fertilization. Contracept Fertil Sex 25:499-502
6. van Hooff MH, Alberda AT, Huisman GJ, Zeilmaker GH, Leerentveld RA (1993) Doubling the human menopausal gonadotrophin dose in the course of an in vitro fertilization treatment cycle in low responders: a randomized study. Hum Reprod 8:369-373 (Pubitemid 23106810)
7. Hoomans EH, Andersen AN, Loft A, Leerentveld RA, van Kamp AA, Zech H (1999) A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon(R)) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP(R)) in a fixed-dose regimen in women undergoing ovarian stimulation. Hum Reprod 14:2442-2447 (Pubitemid 29473907)
8. Hoomans EH, Mulder BB, Asian Purgeon Study Group (2002) A group-comparative, randomized, double-blind comparison of the efficacy and efficiency of two fixed daily dose regimens (100- and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for IVF/ICSI. J Assist Reprod Genet 19:470-476 (Pubitemid 35231179)
9. Wikland M, Bergh C, Borg K, Hillensjo T, Howles CM, Knutsson A et al (2001) A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI. Hum Reprod 16:1676-1681 (Pubitemid 32761749)
10. Yong PY, Brett S, Baird DT, Thong KJ (2003) A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment. Fertil Steril 79:308-315 (Pubitemid 36144054)
11. Fauser BC, Devroey P, Yen SS, Gosden R, Crowley WF Jr, Baird DT, Bouchard P (1999) Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod 14:2681-2686 (Pubitemid 29520671)
12. Fauser BC, Devroey P, Macklon NS (2005) Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 365:1807-1816 (Pubitemid 40744662)
13. Callahan TL, Hall JE, Ettner SL, Christiansen CL, Greene MF, Crowley WF Jr (1994) The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence. N Engl J Med 331:244-249 (Pubitemid 24226684)
14. Gerris J, De Sutter P, De Neubourg D, Van Royen E, Vander EJ, Mangelschots K et al (2004) A real-life prospective health economic study of elective single embryo transfer versus two-embryo transfer in first IVF/ICSI cycles. Hum Reprod 19:917-923 (Pubitemid 38456058)
15. Kjellberg AT, Carlsson P, Bergh C (2006) Randomized single versus double embryo transfer: obstetric and paediatric outcome and a cost-effectiveness analysis. Hum Reprod 21:210-216 (Pubitemid 41794313)
16. Wolner-Hanssen P, Rydhstroem H (1998) Cost-effectiveness analysis of in vitro fertilization: estimated costs per successful pregnancy after transfer of one or two embryos. Hum Reprod 13:88-94 (Pubitemid 28075279)
17. Lukassen HG, Schonbeck Y, Adang EM, Braat DD, Zielhuis GA, Kremer JA (2004) Cost analysis of singleton versus twin pregnancies after in vitro fertilization. Fertil Steril 81:1240-1246 (Pubitemid 38609305)
18. Collins J, Graves G (2000) The economic consequences of multiple gestation pregnancy in assisted conception cycles. Hum Fertil (Camb) 3:275-283 (Pubitemid 32010894)
19. Simon C, Cano F, Valbuena D, Remohi J, Pellicer A (1995) Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 10:2432-2437
20. Simon C, Garcia Velasco JJ, Valbuena D, Peinado JA, Moreno C, Remohi J et al (1998) Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil Steril 70:234-239 (Pubitemid 28361473)
21. Simon C, Domínguez F, Valbuena D, Pellicer A (2003) The role of estrogen in uterine receptivity and blastocyst implantation. Trends Endocrinol Metab 14(5):197-199 (Pubitemid 36841475)
22. Pellicer A, Valbuena D, Cano F, Remohí J, Simón C (1996) Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril 65(6):1190-1195 (Pubitemid 26158638)
23. Ma WG, Song H, Das SK et al (2003) Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad Sci USA 100:2963-2968 (Pubitemid 36297606)
24. Horcajadas JA, Riesewijk A, Polman J, van Os R, Pellicer A, Mosselman S et al (2005) Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod 11(3):195-205 (Epub 2005 Feb 4) (Pubitemid 40662753)
25. Van der Gaast MH, Classen-Linke I, Krusche CA, Beier-Hellwig K, Fauser BC, Beier HM et al (2008) Impact of ovarian stimulation on mid-luteal endometrial tissue and secretion markers of receptivity. Reprod Biomed Online 17(4):553-563
26. Miller BG, Armstrong DT (1981) Superovulatory doses of pregnant mare serum gonadotrophin cause delayed implantation and infertility in immature rats. Biol Reprod 25:253-260 (Pubitemid 11029383)
27. Ertzeid G, Storeng R (1992) Adverse effects of gonadotrophin treatment on pre- and postimplantation development in mice. J Reprod Fertil 96:649-655 (Pubitemid 23035277)
28. Hock DL, Louie H, Shelden RM, Ananth CV, Kemmann E (1998) The need to step up the gonadotrophin dosage in the stimulation phase of IVF treatment predicts a poor outcome. J Assist Reprod Genet 15(7):427-430 (Pubitemid 28376413)
29. Roberts R, Iatropoulou A, Ciantar D, Stark J, Becker DL, Franks S et al (2005) Follicle-stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitro. Biol Reprod 72:107-118 (Pubitemid 40013760)
30. Kaleli S, Yanikkaya-Demirel G, Erel CT, Senturk LM, Topcuoglu A, Irez T (2005) High rate of aneuploidy in luteinized granulosa cells obtained from follicular fluid in women who underwent controlled ovarian hyperstimulation. Fertil Steril 84:802-804 (Pubitemid 41317756)
31. Rubio C, Mercader A, Alama P et al (2010) Prospective cohort study in high responder oocyte donors using two hormonal stimulation protocols: impact on embryo aneuploidy and development. Hum Reprod 25:2290-2297
32. Baart EB, Martini E, Eijkemans MJ et al (2007) Milder ovarian stimulation for in vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod 22(4):980-988
33. Hohmann FP, Macklon NS, Fauser BC (2003) A randomized comparison of two ovarian stimulation protocols with gonadotrophin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab 88(1):166-173 (Pubitemid 36115160)
34. Inge GB, Brinsden PR, Elder KT (2005) Oocyte number per live birth in IVF: were Steptoe and Edwards less wasteful? Hum Reprod 20(3):588-592 (Epub 2005 Feb 2) (Pubitemid 40425480)